ChatDocto
Find a doctor
White scored tablet

MADOPAR 250 mg

Benserazide + Levodopa · quadrisectable tablets

B/100Oral use
76,092 DTRecorded public price · B/100
See all pack prices
Strength250 mg
ATC codeN04BA02

About this medicine

MADOPAR 250 mg quadrisectable tablets is listed in Tunisia's medicine catalog under the active ingredient Benserazide + Levodopa. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

Some catalog records disagree about this product's identity. Clinical guidance is withheld while the records are checked. Confirm the name, strength and form with a pharmacist.

What side effects should I know about?

Review pending

Some catalog records disagree about this product's identity. Clinical guidance is withheld while the records are checked. Confirm the name, strength and form with a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/100

    100 units in this pack

    Recorded public price76,092 DT
    CNAM code
    103333
    CNAM reference amount
    76,000 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formquadrisectable tablets
Route of administrationOral use
ATC codeN04BA02 — Lévodopa et inhibiteur de la décarboxylase